📰 Express Scripts News
Page 63 - Express Scripts News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Express Scripts. Real-time updates on events, politics, business and more.
July 7, 2023
At least nine bills introduced in Congress take aim at pharmacy benefit managers, the powerful middlemen that channel prescription drugs to patients. Here's what the fuss is all about.
July 6, 2023
LOS ANGELES (Legal Newsline) - California Attorney General Rob Bonta will get his wish that his lawsuit over insulin prices will be heard in Los Angeles state court, rather than federal court.
July 5, 2023
The generic drug unit of Germanys Fresenius said on Monday the price for Idacio, its copycat version of Abbvies top-selling rheumatoid arthritis drug, will be at a 5% discount to Humiras list price.
July 5, 2023
Federal Trade Commissioner Alvaro Bedoya participated in a roundtable discussion about PBM contracting practices on Jun. 29 at Eric’s RX Shoppe in Horsham, Pa., which included several independent pharmacy owners from Pennsylvania and staff with the Pennsylvania Pharmacists Association and the Philadelphia Association of Retail Druggists, as well as NCPA.
July 4, 2023
Commission pauses major biopharma transaction involving drugs priced in the hundreds of thousands of dollars. As part of the Federal Trade Commissions promised campaign to protect competition in the...
July 3, 2023
/PRNewswire/ -- Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving nearly 38 million members nationally, today announced that Mostafa...
July 3, 2023
(Reuters) - The generic drug unit of Germany's Fresenius said on Monday the price for Idacio, its copycat version of Abbvie's top-selling rheumatoid a...
July 3, 2023
Drugmaker partners Organon and Samsung Bioepis said on Saturday that they had launched a far cheaper copycat version of AbbVie’s blockbuster arthritis drug Humira.
July 3, 2023
Fresenius joins drugmakers Boehringer Ingelheim, Sandoz and Organon, which launched Humira biosimilars, or copies of biologic drugs, this week. Industry experts have said that most new biosimilars are expected to debut with marginal discounts to Humira's monthly price of $6,922.
July 1, 2023
Drugmaker partners Organon and Samsung Bioepis said on Saturday that they had launched a far cheaper copycat version of AbbVies blockbuster arthritis drug Humira, while another drugmaker entered...